TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$176,61
Dagwisseling
$168,43 - $176,34
Jaarwisseling
$59,80 - $177,00
Markkapitalisasie
23,10 mjd USD
Gemiddelde volume
1,11 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 439,76 m | 63,90% |
Bedryfskoste | 311,08 m | 34,10% |
Netto inkomste | -31,59 m | 71,02% |
Netto winsgrens | -7,18 | 82,33% |
Wins per aandeel | -0,26 | 72,63% |
EBITDA | -31,14 m | 70,06% |
Effektiewe belastingkoers | -2,37% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 922,33 m | -1,52% |
Totale bates | 1,59 mjd | 9,98% |
Totale aanspreeklikheid | 712,42 m | 7,64% |
Totale ekwiteit | 878,52 m | — |
Uitstaande aandele | 132,02 m | — |
Prys om te bespreek | 24,94 | — |
Opbrengs op bates | -6,33% | — |
Opbrengs op kapitaal | -7,48% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -31,59 m | 71,02% |
Kontant van bedrywe | 51,79 m | 274,37% |
Kontant van beleggings | 42,54 m | -47,67% |
Kontant van finansiering | 1,72 m | -99,27% |
Netto kontantverandering | 96,05 m | -66,60% |
Beskikbare kontantvloei | 40,19 m | 1 066,44% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
3 288
